Scrip Regulatory Affairs
The New EU Data Protection Regulation: What will the Impact be on the Life Sciences Industry?
March 2012
The EU Data Protection Regulation proposed by the European Commission in January will - if adopted in its current form - require pharmaceutical and medical device companies to adopt a new approach to data processing and data protection.
This article was published in the March 2012 issue of Scrip Regulatory Affairs.
Contacts
Capabilities
Suggested News & Insights
New York Department of Financial Services Issues Coordinated Guidance on Frontier AI Cybersecurity RisksMay 28, 2026Chambers 2026 Global Practice Guide for Artificial IntelligenceMay 27, 2026Sidley Represents Passport Global in Its US$425 Million Agreement to Be Acquired by Global-e (Nasdaq: GLBE)May 27, 2026Chambers 2026 Global Practice Guide for Artificial IntelligenceMay 2026Sidley Represents Nourish in US$100 Million Series C FinancingMay 19, 2026PRA Proposes Tighter Capital and Risk Framework for Funded ReinsuranceMay 13, 2026
- Stay Up To DateSubscribe to Sidley Publications
- Follow Sidley on Social MediaSocial Media Directory
